A Reason Why Drug Companies May Be Averse to Off Label Therapeutics

A Reason Why Drug Companies May Be Averse to Off Label Therapeutics

Paul is an amazing Kool Been. He is hoping for an end to the pandemic, hence, his been name is EndBeen. He is BS ChE and Six Sigma Black Belt (process focusing on the practical application of statics to real world problems).  Retired.  Volunteer teaching STEM (Science, Technology, Engineering and Math) at local schools.

Paul and I were speaking a few days ago and he mentioned the pharma companies and their legal exposures from the past cases. I thought it was a good topic to discuss at our coffee table. Let's hear his observations.

Buy me a coffee :-) https://www.buymeacoffee.com/DrMobeenSyed
Become my patron: https://www.patreon.com/mobeensyed?fan_landing=true
Looking to support my educational work? Donate here: https://paypal.me/mobeensyed?locale.x=en_US

#drbeen #koolbeens #COVID

Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.

Видео A Reason Why Drug Companies May Be Averse to Off Label Therapeutics канала Drbeen Medical Lectures